Specifically, AR is a direct target of the driver oncogene mechanistic target of rapamycin complex 1 (mTORC1), which promotes cell metabolism and proliferation in vitro and contributes to the development of liver steatosis and HCC in vivo through AR phosphorylation10. Here, AR is linked to hepatocellular carcinoma.